Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(1.68)
# 2,997
Out of 4,829 analysts
92
Total ratings
23.33%
Success rate
-9.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $6.82 | +486.51% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.31 | +663.36% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $1.38 | +334.78% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $4.55 | +185.71% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $2 | $0.88 | +127.76% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $3.24 | +609.88% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $25.22 | +197.38% | 13 | Apr 28, 2025 | |
| IBRX ImmunityBio | Reiterates: Buy | $8 | $2.26 | +253.98% | 2 | Apr 16, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $36 | $6.59 | +446.28% | 14 | Apr 3, 2025 | |
| MURA Mural Oncology | Maintains: Buy | $18 → $6 | $2.61 | +130.33% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.85 | +1,664.91% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.76 | +805.80% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $32.01 | +56.20% | 13 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.14 | +250.88% | 11 | Nov 11, 2024 |
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $6.82
Upside: +486.51%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.31
Upside: +663.36%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $1.38
Upside: +334.78%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $4.55
Upside: +185.71%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $2
Current: $0.88
Upside: +127.76%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $3.24
Upside: +609.88%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $25.22
Upside: +197.38%
ImmunityBio
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $2.26
Upside: +253.98%
Day One Biopharmaceuticals
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $6.59
Upside: +446.28%
Mural Oncology
Mar 26, 2025
Maintains: Buy
Price Target: $18 → $6
Current: $2.61
Upside: +130.33%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.85
Upside: +1,664.91%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $2.76
Upside: +805.80%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $32.01
Upside: +56.20%
Nov 11, 2024
Reiterates: Buy
Price Target: $4
Current: $1.14
Upside: +250.88%